Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Am J Cardiol. 2019 Jan 1;123(1):108-115. doi: 10.1016/j.amjcard.2018.09.018. Epub 2018 Oct 3.
We evaluated temporal trends in gender-related differences in patients who underwent transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis from a multicenter TAVI registry during the years 2008 to 2016. Our final cohort included 1,159 males and 1,370 females, with a median follow-up of 2.3 (IQR 1.2, 4.4) years. For temporal trends analysis, the entire population was divided according to period of procedure: 2008 to 2012 and 2013 to 2016. During the 2008 to 2012 period, the rates of in-hospital aortic paravalvular leak, myocardial infarction, pacemaker implantation, and stroke were higher among men than women, but became comparable between the gender during the 2013 to 2016 period. Multivariate analysis demonstrated that female patients who underwent TAVI between the years 2008 and 2012 had a 26% lower risk of death compared with male patients (p = 0.004), but there were no gender-related differences in mortality risk between the years 2013 and 2016 (hazard ratio 1.07, p = 0.6; gender-by-year of procedure, p = 0.027 for interaction). In conclusion, the favorable long-term prognosis described in female patients during the earlier TAVI period seemed to diminish with contemporary TAVI. This might be attributed to current technological advances and improved valve sizing, with a more significant benefit in favor of male patients.
我们评估了 2008 年至 2016 年期间,多中心经导管主动脉瓣植入术(TAVI)治疗严重症状性主动脉瓣狭窄患者的性别相关差异的时间趋势。我们的最终队列包括 1159 名男性和 1370 名女性,中位随访时间为 2.3(IQR1.2,4.4)年。为了进行时间趋势分析,根据手术时期将整个人群分为两个时期:2008 年至 2012 年和 2013 年至 2016 年。在 2008 年至 2012 年期间,男性患者的院内主动脉瓣周漏、心肌梗死、起搏器植入和中风发生率高于女性,但在 2013 年至 2016 年期间,男女之间的发生率变得相当。多变量分析表明,与男性患者相比,2008 年至 2012 年间接受 TAVI 的女性患者死亡风险降低了 26%(p=0.004),但在 2013 年至 2016 年间,男女之间的死亡率无差异(风险比 1.07,p=0.6;手术时期的性别-年交互作用,p=0.027)。总之,在较早的 TAVI 时期女性患者描述的有利长期预后似乎随着当代 TAVI 而减少。这可能归因于当前技术的进步和瓣膜尺寸的改善,男性患者获益更为显著。